The amended Patent Examination Guidelines further state that "if the applicant becomes aware of Circumstance 4 only after receiving a notification from the CNIPA, it should submit a response within the specified deadline specified in the notification, stating their opinion regarding not losing the nove...
Article 75.2 allows patentees or interested parties to block the marketing of a new drug whose technical solutions fall within the scope of protection of the patent published by the patent registration platform for marketed drugs. Viable options include patent litigation before the cou...
any party may, during the prosecution of a patent application, file a third-party observation to assist the examiner to examine, by reviewing the brief of the third-party observation and evidence, the novelty or inventive step of the claimed invention...